Effects of exercise training on nitric oxide metabolites in heart failure with reduced or preserved ejection fraction: a secondary analysis of the SMARTEX-HF and OptimEx-Clin trials.
Eur J Prev Cardiol. 2025 Aug 25;32(11):949-960. doi: 10.1093/eurjpc/zwaf142.
Nat Med. 2025 Jan;31(1):306-314. doi: 10.1038/s41591-024-03342-7.
Trans-fatty acid blood levels of industrial but not natural origin are associated with cardiovascular risk factors in patients with HFpEF: a secondary analysis of the Aldo-DHF trial.Clin Res Cardiol. 2023 Nov;112(11):1541-1554. doi: 10.1007/s00392-022-02143-7.
De Novo Lipogenesis-Related Monounsaturated Fatty Acids in the Blood Are Associated with Cardiovascular Risk Factors in HFpEF Patients.J Clin Med. 2023 Jul 27;12(15):4938. doi: 10.3390/jcm12154938.
Effect of Training on Vascular Function and Repair in Heart Failure With Preserved Ejection Fraction.JACC Heart Fail. 2023 Apr;11(4):454-464. doi: 10.1016/j.jchf.2022.12.011.
Peak O2 -pulse predicts exercise training-induced changes in peak V̇O2 in heart failure with preserved ejection fraction.ESC Heart Fail. 2022 Oct;9(5):3393-3406. doi: 10.1002/ehf2.14070.
Saturated Fatty Acid Blood Levels and Cardiometabolic Phenotype in Patients with HFpEF: A Secondary Analysis of the Aldo-DHF Trial.Biomedicines. 2022 Sep 15;10(9):2296.
Cardiovascular risk factors, exercise capacity and health literacy in patients with chronic ischaemic heart disease and type 2 diabetes mellitus in Germany: Baseline characteristics of the Lifestyle Intervention in Chronic Ischaemic Heart Disease and Type 2 Diabetes study.Diab Vasc Dis Res. 2022 Jul-Aug;19(4):14791641221113781.
Omega-3 fatty acid blood levels are inversely associated with cardiometabolic risk factors in HFpEF patients: the Aldo-DHF randomized controlled trial.Clin Res Cardiol. 2022 Mar;111(3):308-321.
Iron Deficiency Impacts Diastolic Function, Aerobic Exercise Capacity, and Patient Phenotyping in Heart Failure With Preserved Ejection Fraction: A Subanalysis of the OptimEx-Clin Study.Front Physiol. 2022 Feb 10;12:757268.
miR-181c level predicts response to exercise training in patients with heart failure and preserved ejection fraction: an analysis of the OptimEx-Clin trial.Eur J Prev Cardiol. 2021 Dec 29;28(15):1722-1733.
Cluster Randomized Controlled Trial on the Effects of 12 Months of Combined Exercise Training during Hemodialysis in Patients with Chronic Kidney Disease-Study Protocol of the Dialysis Training Therapy (DiaTT) Trial.Methods Protoc. 2021 Aug 31;4(3):60.
The Effect of Exercise Intensity and Volume on Metabolic Phenotype in Patients with Metabolic Syndrome: A Randomized Controlled Trial.Metab Syndr Relat Disord. 2021 Mar;19(2):107-114.
Effect of High-Intensity Interval Training, Moderate Continuous Training, or Guideline-Based Physical Activity Advice on Peak Oxygen Consumption in Patients With Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial.
JAMA. 2021 Feb 9;325(6):542-551. doi: 10.1001/jama.2020.26812.
Lifestyle Intervention in Chronic Ischaemic Heart Disease and Type 2 Diabetes (the LeIKD study): study protocol of a prospective, multicentre, randomised, controlled trial.
BMJ Open. 2021 Feb 8;11(2):e042818. doi: 10.1136/bmjopen-2020-042818.
The Effect of Exercise Intensity and Volume on Metabolic Phenotype in Patients with Metabolic Syndrome: A Randomized Controlled Trial.
Metab Syndr Relat Disord. 2021 Mar;19(2):107-114. doi: 10.1089/met.2020.0105. Epub 2020 Nov 24.
Outcome assessment using estimation of left ventricular filling pressure in asymptomatic patients at risk for heart failure with preserved ejection fraction.
Int J Cardiol Heart Vasc. 2020 May 7;28:100525. doi: 10.1016/j.ijcha.2020.100525.
Exercise training in patients with a left ventricular assist device (Ex-VAD): rationale and design of a multicentre, prospective, assessor-blinded, randomized, controlled trial.
Eur J Heart Fail. 2019 Sep;21(9):1152-1159. doi: 10.1002/ejhf.1431. Epub 2019 Mar 28.
Relationship between exercise intervention and NO pathway in patients with heart failure with preserved ejection fraction.
Biomarkers. 2018 Sep;23(6):540-550. doi: 10.1080/1354750X.2018.1460762. Epub 2018 Apr 12.
Amount or intensity? Potential targets of exercise interventions in patients with heart failure with preserved ejection fraction.
ESC Heart Fail. 2018 Feb;5(1):53-62. doi: 10.1002/ehf2.12227. Epub 2017 Dec 6.
Atrial fibrillation in retinal vascular occlusion disease and non-arteritic anterior ischemic optic neuropathy.
PLoS One. 2017 Aug 3;12(8):e0181766. doi: 10.1371/journal.pone.0181766. eCollection 2017.
Exercise training in Diastolic Heart Failure (Ex-DHF): rationale and design of a multicentre, prospective, randomized, controlled, parallel group trial.
Eur J Heart Fail. 2017 Aug;19(8):1067-1074. doi: 10.1002/ejhf.862. Epub 2017 May 17.
Ghrelin and hormonal markers under exercise training in patients with heart failure with preserved ejection fraction: results from the Ex-DHF pilot study.
ESC Heart Fail. 2017 Feb;4(1):56-65. doi: 10.1002/ehf2.12109. Epub 2016 Aug 31.
[Exercise training in the therapy of heart diseases: Current evidence and future options].
Herz. 2016 Mar;41(2):159-69; quiz 170-1. doi: 10.1007/s00059-016-4403-y.
Determinants of submaximal exercise capacity in patients at risk for heart failure with preserved ejection fraction-results from the DIAST-CHF study.
ESC Heart Fail. 2015 Jun;2(2):76-84. doi: 10.1002/ehf2.12034. Epub 2015 Apr 27.
Galectin-3 in patients with heart failure with preserved ejection fraction: results from the Aldo-DHF trial.
Eur J Heart Fail. 2015 Feb;17(2):214-23. doi: 10.1002/ejhf.203. Epub 2014 Nov 24.
Associations of methylarginines and homoarginine with diastolic dysfunction and cardiovascular risk factors in patients with preserved left ventricular ejection fraction.
J Card Fail. 2014 Dec;20(12):923-30. doi: 10.1016/j.cardfail.2014.09.004. Epub 2014 Sep 16.
Effects of exercise training on different quality of life dimensions in heart failure with preserved ejection fraction: the Ex-DHF-P trial.
Eur J Prev Cardiol. 2015 May;22(5):582-93. doi: 10.1177/2047487314526071. Epub 2014 Mar 13.
Differential interaction of clinical characteristics with key functional parameters in heart failure with preserved ejection fraction–results of the Aldo-DHF trial.
Int J Cardiol. 2013 Nov 30;169(6):408-17. doi: 10.1016/j.ijcard.2013.10.018. Epub 2013 Oct 11.
Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial.
JAMA. 2013 Feb 27;309(8):781-91. doi: 10.1001/jama.2013.905.
[Neurohormonal activation and maximal exercise capacity in diastolic dysfunction and diastolic heart failure].
Dtsch Med Wochenschr. 2011 Apr;136(16):810-5. doi: 10.1055/s-0031-1275809. Epub 2011 Apr 12.
Impaired physical quality of life in patients with diastolic dysfunction associates more strongly with neurohumoral activation than with echocardiographic parameters: quality of life in diastolic dysfunction.
Am Heart J. 2011 Apr;161(4):797-804. doi: 10.1016/j.ahj.2011.01.003.
